XAIR — Beyond Air Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $2.24 Analyst target: $20.00 Upside: 792.86%

About Beyond Air Inc

Beyond Air, Inc., a clinical-stage biopharmaceutical and medical device company, develops nitric oxide (NO) generators and delivery systems. The company is headquartered in Garden City, New York.

See the full interactive analysis & chart →

Informational only — not investment advice.